Skip to content
Governance Register

← US public companies

PLx Pharma Inc.

SEC CIK 1497504 · PLXP · last insider filing 2022-03-16

Directors (from insider filings)

NameCapacity as filedFilings
Giordano Natasha Director · President and CEO filed 2017 - 2022
Hadden John Director filed 2017 - 2022
Calhoun Kirk K Director filed 2017 - 2022
Valentino Michael J Director · Executive Chairman filed 2017 - 2022
Balkema Gary S. Director filed 2017 - 2022
Casale Robert Director filed 2017 - 2022
Bartsh Anthony Director filed 2019 - 2019
Luci David P Director · President, CEO, Secretary filed 2014 - 2017
Deluccia Robert J Director · Executive Chairman filed 2014 - 2017
Harrison Thomas L Director filed 2014 - 2017
Dean Jack H Director filed 2014 - 2017
Mcsherry, Jr. William J. Director filed 2014 - 2017
Duffy Michael E. Director filed 2014 - 2017
Kagan Barry Director filed 2015 - 2017
Coughlin Christopher J Director filed 2014 - 2014

Officers (from insider filings)

NameTitle as filedFilings
O'Connor Rita M Chief Financial Officer filed 2017 - 2022
Deliargyris Efthymios Chief Medical Officer filed 2018 - 2020
Mossman Gary L Chief Operating Officer filed 2017 - 2017
Jorden David Emerson Acting Chief Financial Officer filed 2017 - 2017
Dillon Michael J. VP, Sales and Marketing filed 2017 - 2017
Shawah Robert G. Chief Accounting Officer, Trea filed 2014 - 2017
Garrett David VP, Finance and Corp. Dev. filed 2014 - 2016

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.